TrialsgrambetaRCTs are beautiful

PIONEER-HF

2019

Comparison of Sacubitril/Valsartan versus Enalapril on Effect on NT-proBNP in Patients Stabilized from an Acute Heart Failure Episode

In 881 patients hospitalised for acute decompensated HFrEF, in-hospital initiation of sacubitril/valsartan lowered NT-proBNP more than enalapril.

Result

Time-averaged proportional change in NT-proBNP through weeks 4 and 8
Effect estimate

ratio0.7195% CI 0.63-0.81 · P < 0.001

Also reported: With no excess of key safety events.

Original publication
Subtopic
ARNI
Design
Double-blind active-controlled RCT
Relevance
Important: one of several pillars.
Source
Velazquez EJ, et al. N Engl J Med. 2019;380(6):539-548.doi 10.1056/NEJMoa1812851

Discussion & critique

Biomarker (NT-proBNP) primary endpoint rather than clinical outcomes, and short 8-week duration. Demonstrated safe in-hospital initiation of ARNI in stabilised acute HFrEF, shifting practice toward starting sacubitril/valsartan before discharge.

Discussed in podcasts